Top Markets
#1 0G 0G +24.46%
#2 SAFEcoin SAFEcoin +21.99%
#3 Zora Zora +20.33%
#4 Axelar Axelar +19.88%
#5 Full Moon Full Moon +18.98%
#6 AI XOVIA AI XOVIA +17.52%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.60%
#8 Cysic Cysic +16.30%
#9 VVS Finance VVS Finance +15.88%
#10 Apertum Apertum +13.84%
Coin of the day
0G 0G
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Classificação em ações #12783
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Preço da ação
$5.87
Última sincronização: 2022-11-08
Valor de mercado
$550.43M
Variação (1 dia)
1.03%
Variação (1 ano)
0.00%
País
US
Negociar Silverback Therapeutics, Inc. (SBTX)

Categoria

Healthcare
Histórico de preços das ações de Silverback Therapeutics, Inc. (SBTX)
Preço de fecho mais alto: $6.02 em 2022-11-01

Preço de fecho mais baixo: $33.40 em 2020-12-01
Histórico de preços das ações da Silverback Therapeutics, Inc. de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2022 -10.00%
2021 -79.97%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH